INVESTOR ALERT: Levi & Korsinsky, LLP Launches Investigation of the Board of Directors of Durata Therapeutics Inc. Concerning...
October 14 2014 - 12:36PM
Business Wire
Levi & Korsinsky is investigating the Board of Directors of
Durata Therapeutics Inc. (“Durata” or “the Company”) (NASDAQ: DRTX)
for possible breaches of fiduciary duty and other violations of
state law in connection with the sale of the Company to Actavis
(NYSE:ACT).
Click here to learn more about the investigation:
http://zlk.9nl.com/durata-therapeutics-drtx.
Under the terms of the transaction, Durata shareholders will
receive $23.00 in cash for each share of Durata stock they own, as
well as contingent value rights entitling the holder to receive
additional cash payments of up to $5.00 per share upon certain
achieved milestones. The investigation concerns whether the Board
of Durata breached their fiduciary duties to stockholders by
failing to adequately shop the Company before agreeing to enter
into this transaction, and whether Actavis is underpaying for
Durata shares.
If you own Durata common stock and wish to obtain additional
information, please contact Joseph E. Levi, Esq. either via email
at jlevi@zlk.com or by telephone at (212) 363-7500, toll-free:
(877) 363-5972, or visit
http://zlk.9nl.com/durata-therapeutics-drtx.
Levi & Korsinsky is a national firm with offices in New
York, New Jersey, Connecticut and Washington D.C. The firm’s 26
attorneys have extensive expertise in prosecuting securities
litigation involving financial fraud, representing investors
throughout the nation in securities and shareholder lawsuits. For
more information, please feel free to contact any of the attorneys
listed below. Attorney advertising. Prior results do not guarantee
similar outcomes.
Levi & Korsinsky, LLPJoseph Levi, Esq.Eduard Korsinsky,
Esq.Tel: 212-363-7500Toll Free: 877-363-5972Fax:
866-367-6510www.zlk.com
(MM) (NASDAQ:DRTX)
Historical Stock Chart
From Sep 2024 to Oct 2024
(MM) (NASDAQ:DRTX)
Historical Stock Chart
From Oct 2023 to Oct 2024